Physician profile
Ally Gordon
NPI 1487832663
$5,696.95
in general payments reported to CMS, 2019-2025
35 companies · $1,299 in 2025
The $1,299 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,354 · 2022: $1,030 · 2023: $908 · 2024: $1,106 · 2025: $1,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,972 · Education: $229 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,972.23 |
| Education | $229.05 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,155.87 | 2021-2023 | Axonics |
| Sumitomo Pharma America, INC. | $756.91 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $645.72 | 2023-2025 | |
| Astellas Pharma US INC | $614.64 | 2021-2024 | Xtandi, Myrbetriq |
| Medtronic, INC. | $559.52 | 2023-2025 | Interstim, Altaviva |
| Urovant Sciences INC | $410.62 | 2021-2022 | |
| Janssen Biotech, INC. | $274.14 | 2022-2025 | Erleada |
| Teleflex LLC | $185.36 | 2022-2024 | Solesta |
| Immunitybio, INC. | $135.17 | 2025 | |
| Merck Sharp & Dohme LLC | $102.97 | 2021-2024 | Keytruda |
| Urogen Pharma, INC. | $76.05 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $70.86 | 2022 | |
| 180 Medical, INC. | $60.96 | 2022-2023 | Cure Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $58.61 | 2021-2023 | |
| Antares Pharma, INC. | $45.83 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $44.42 | 2025 | Ecoin Device Kit |
| Progenics Pharmaceuticals, INC. | $43.05 | 2023 | Pylarify |
| Ferring Pharmaceuticals INC. | $39.51 | 2024 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Millicent US INC | $34.81 | 2024 | Intrarosa, Femring |
| Myriad Genetic Laboratories, INC. | $33.98 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $33.78 | 2025 | |
| Amgen INC. | $29.44 | 2021-2023 | Prolia |
| Alnylam Pharmaceuticals INC. | $27.83 | 2023 | Givlaari |
| Pfizer INC. | $27.67 | 2022 | |
| Tempus Ai, INC | $27.14 | 2024 | Xt Cdx |
| Accord Healthcare, INC. | $22.30 | 2024 | |
| Convatec INC. | $21.88 | 2022 | |
| Clarus Therapeutics INC. | $21.53 | 2021 | |
| Novo Nordisk INC | $18.86 | 2023 | Ozempic, Rybelsus |
| Coloplast Corp | $17.19 | 2024 | |
| Hollister Incorporated | $17.05 | 2023 | Infyna Chic |
| Endo Pharmaceuticals INC. | $16.54 | 2023 | Aveed, Xiaflex, Edex |
| Dentsply Ih Ab | $15.97 | 2023 | Lofric |
| Abc Home Medical Supply, INC. | $15.71 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ally Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.